Showing 1–12 of 226 results
Discovery and development of new molecules directed against validated pain targets is required to advance the treatment of pain disorders.…
Read MoreAs key mediators of immune responses, cytokines have emerged as major drug targets for inflammatory and autoimmune diseases. A significant…
Read MoreIn this webinar, Eurofins DiscoverX and Latigo Therapeutics come together to present recent advances in ion channel drug discovery focusing…
Read MoreIn this webinar, Eurofins DiscoverX and Latigo Therapeutics come together to present recent advances in ion channel drug discovery focusing…
Watch NowCase studies on the use of cell-based assays that monitor receptor dimerization and signaling reporter activation targeting IL-12, IL-23, IL-15,…
Read MoreCase studies on the characterization & clinical development of agonistic antibody therapeutics targeting checkpoint receptors.
Read MoreJennifer Lin-Jones, Ph.D., Associate Director of Assay Development R&D Department, Eurofins DiscoverX
Read MoreWatch this webinar to discover functional cell-based assays for characterizing novel therapeutics & biosimilars targeting cytokines in inflammation & oncology.
Watch NowStriatal-enriched protein tyrosine phosphatase (STEP) is a brain-specific enzyme that regulates the signaling molecules that control synaptic plasticity and neuronal…
Read MoreThe MAS-related Gq protein-coupled receptor X4 (MRGPRX4) is poorly investigated. MRGPRX4 has been proposed to be involved in pain transmission,…
Read MoreAgonistic Antibodies and the Role of Checkpoint Receptors in Immune Function
Read MoreThe clinical success of an ever-increasing array of biologics has led to the development of a wide spectrum of immunomodulatory…
Read More
